• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Occlusion (1984); Patient Problem/Medical Problem (2688)
Event Date 06/08/2018
Event Type  Injury  
Manufacturer Narrative
Date article was accepted journal article title: mobility of an in-stent plaque protrusion detected with carotid duplex during the carotid artery stenting procedure: a case report kanta tanaka et al med ultrason 2019, vol.21, no.1, 89-92 doi: 10.11152/mu-1539.If information is provided in the future, a supplemental report will be issued.
 
Event Description
This article reports on a patient with symptomatic right carotid artery stenosis the patient was diagnosed as having a cerebral infarction due to atherosclerotic artery-to-artery embolization.Patient had undergone medical treatment with aspirin, clopidogrel, argatroban, and atorvastatin, but left hemiparesis is reported to have worsened because of a recurrent attack on day 2 after admission.Diffusion-weighted imaging (dwi) showed several newly appeared infarcts at the right middle cerebral artery territory.Patient required early intervention due to experiencing recurrent ischemic stroke under the intensive medical therapy.Considering the allergy to iodinated contrast and the unstable nature of the responsible plaque, carotid endarterectomy (cea) was recommended.The patient desired a less invasive treatment, so a carotid duplex-assisted carotid artery stenting (cas) procedure which could be performed with the administration of local anaesthesia was carried out.Fluoroscopic imaging was performed using a biplane flat detector angiography carotid duplex was performed by an experienced sonographer using a 12-mhz linear array transducer.Intravascular ultrasonography was also used.After an 8-fr sheath was inserted through the right femoral artery, 5000 iu of heparin sodium was intravenously administered.An 8-fr curved guiding catheter was fluoroscopically placed into the innominate artery.A non-medtronic embolic protection device was fluoroscopically guided into the right common carotid artery.Under duplex guidance, the embolic protection device crossed the lesion and advanced into the right internal carotid artery (ica).The filter was opened under fluoroscopy in the distal extracranial right ica.Stent size was determined on the basis of the ivus measurement of arterial diameters and lesion length and level.Using carotid duplex monitoring, a protégé rx 9×60-mm stent was positioned and deployed.Following this, ivus revealed a small in-stent plaque protrusion (isp) with no distinct characteristics.The isp was attempted to be observed using extravascular carotid duplex, and the mobile features of the protrusion were disclosed.To prevent distal embolization, stent-in-stent implantation using a non-medtronic 9x30mm stent was performed.No remaining protrusions were observed with either ivus or carotid duplex, and the patient experienced no periprocedural strokes.Carotid duplex performed at 14 days and 6 months after the procedure showed no protrusion or restenosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8494739
MDR Text Key141311590
Report Number2183870-2019-00166
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 04/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/09/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/26/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age87 YR
-
-